Clinical Report: The Relationship Between Pediatric Heart Disease and Foster Care Status
Overview
This multicenter retrospective cohort study reveals that children and youth in foster care (CYFC) with heart disease exhibit greater medical complexity and socioeconomic disadvantage, resulting in a 22% longer hospital length of stay compared to their peers not in foster care. However, in-hospital mortality and 30-day readmission rates were similar between the two groups.
Background
Children and youth in foster care face significant medical, social, and economic challenges that contribute to health disparities, particularly in pediatric cardiology. Understanding the intersection of foster care status and heart disease is crucial for developing targeted interventions to improve health outcomes in this vulnerable population. Despite the known risks, there is a lack of comprehensive data on the clinical characteristics and outcomes of CYFC with heart disease.
Data Highlights
Metric
CYFC with Heart Disease
Children Not in Foster Care
Hospital Length of Stay
22% longer
Standard
In-Hospital Mortality
No difference
No difference
30-Day Readmission Rates
No difference
No difference
Key Findings
CYFC with heart disease have greater medical complexity.
They are more likely to experience socioeconomic disadvantage.
Hospital length of stay is 22% longer for CYFC compared to non-foster care peers.
In-hospital mortality rates do not differ between the two groups.
30-day readmission rates are similar for both groups.
Clinical Implications
Recognizing foster care status as a significant social determinant of health is essential for improving care coordination and discharge planning for CYFC with heart disease. Targeted interventions may be necessary to address the unique challenges faced by this population.
Conclusion
The study highlights the need for enhanced understanding and support for CYFC with heart disease, emphasizing the importance of addressing social determinants of health in pediatric cardiology.
A Keck Medicine of USC cardiothoracic surgeon explains why epicardial ablation may be the right treatment for some patients with longstanding persistent AFib.
